Cargando…
Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
Although universal vaccination is one of the most important healthcare strategies for limiting SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) circulation and averting the huge number of hospitalizations and deaths due to coronavirus disease 2019 (COVID-19), significant inter-individual...
Autores principales: | Lippi, Giuseppe, Henry, Brandon Michael, Plebani, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228868/ https://www.ncbi.nlm.nih.gov/pubmed/34070341 http://dx.doi.org/10.3390/diagnostics11060941 |
Ejemplares similares
-
The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
SARS-CoV-2 antibodies titration: a reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2020) -
LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants
por: Lippi, Giuseppe, et al.
Publicado: (2023) -
Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022)